Literature DB >> 25990068

Vasculopathies of Neurofibromatosis Type 1 (von Recklinghausen Disease).

J T Lie1.   

Abstract

Vasculopathies are the least publicized but most important manifestation of neurofibromatosis type 1 (NF1, or, von Recklinghausen disease) as the cause of morbidity and mortality in children and young adults afflicted with the disease. Occlusive or aneurysmal disease of arteries of all sizes may occur almost anywhere in the body. Coarctation or segmental hypoplasia of the abdominal aorta with or without renal artery ostial stenosis is a common cause of renovascular hypertension. Although rare, occlusive coronary artery disease in NF1 may result in myocardial infarction and sudden unexpected death. Visceral vasculopathy causes ischemic bowel disease; and catastrophic retroperitoneal or abdominal hemorrhage has been attributed to spontaneously ruptured arterial aneurysms. Peripheral vascular disease in NF1 with limb ischemia requiring an amputation is described for the first time here. Scanty information exists in the current pathology literature on NF1 vasculopathies, hence the presentation of this review.
Copyright © 1998 Elsevier Science Inc. All rights reserved.

Entities:  

Year:  1998        PMID: 25990068     DOI: 10.1016/S1054-8807(97)00081-1

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  9 in total

Review 1.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

2.  Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.

Authors:  Waylan K Bessler; Grace Kim; Farlyn Z Hudson; Julie A Mund; Raghuveer Mali; Keshav Menon; Reuben Kapur; D Wade Clapp; David A Ingram; Brian K Stansfield
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

3.  Histologic and morphologic character of pediatric renal artery occlusive disease.

Authors:  Dawn M Coleman; Amer Heider; David Gordon; Santhi K Ganesh; Jonathan L Eliason; James C Stanley
Journal:  J Vasc Surg       Date:  2020-04-08       Impact factor: 4.268

4.  Inside and Out.

Authors:  Maximilian F Konig; Vasanth Sathiyakumar; Casey M Phan; Steven P Schulman; Allan C Gelber
Journal:  N Engl J Med       Date:  2021-05-06       Impact factor: 91.245

5.  Severe dyspnea in a patient with neurofibromatosis type 1.

Authors:  P B Poble; J C Dalphin; B Degano
Journal:  Respir Med Case Rep       Date:  2017-06-17

6.  Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1.

Authors:  Michaël Noë; Antonio Pea; Claudio Luchini; Matthäus Felsenstein; Stefano Barbi; Feriyl Bhaijee; Raluca Yonescu; Yi Ning; N Volkan Adsay; Giuseppe Zamboni; Rita T Lawlor; Aldo Scarpa; G Johan A Offerhaus; Lodewijk A A Brosens; Ralph H Hruban; Nicholas J Roberts; Laura D Wood
Journal:  Mod Pathol       Date:  2018-05-30       Impact factor: 7.842

Review 7.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

8.  Myocardial Infarction in a 28-Year-Old Male With Neurofibromatosis Type 1.

Authors:  Mitra Patel; Dipen Patel; Christian Nehme; Amala Ambati; Carson E Oostra
Journal:  Cureus       Date:  2020-10-30

9.  Neurofibromatosis type 1 complicated by atypical coarctation of the thoracic aorta.

Authors:  Masato Kimura; Shuhei Kakizaki; Kengo Kawano; Shinichi Sato; Shigeo Kure
Journal:  Case Rep Pediatr       Date:  2013-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.